Lombard Odier Asset Management Switzerland SA Increases Stock Holdings in The Clorox Company $CLX

Lombard Odier Asset Management Switzerland SA grew its stake in shares of The Clorox Company (NYSE:CLX) by 7.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 108,600 shares of the company’s stock after purchasing an additional 7,600 shares during the quarter. Lombard Odier Asset Management Switzerland SA owned approximately 0.09% of Clorox worth $11,254,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. Caitlin John LLC grew its position in shares of Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after buying an additional 253 shares during the last quarter. Darwin Wealth Management LLC purchased a new stake in Clorox in the second quarter valued at $29,000. Vision Financial Markets LLC lifted its position in Clorox by 166.7% in the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after acquiring an additional 200 shares during the last quarter. Root Financial Partners LLC boosted its stake in Clorox by 83.8% in the first quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after acquiring an additional 145 shares in the last quarter. Finally, SHP Wealth Management purchased a new position in shares of Clorox during the fourth quarter worth about $35,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE:CLX opened at $95.61 on Friday. The company has a 50-day simple moving average of $95.10 and a 200-day simple moving average of $103.83. The Clorox Company has a one year low of $84.70 and a one year high of $131.86. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The stock has a market capitalization of $11.56 billion, a price-to-earnings ratio of 15.52 and a beta of 0.54.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business’s revenue was up .1% on a year-over-year basis. During the same quarter last year, the company posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, analysts predict that The Clorox Company will post 5.52 EPS for the current year.

Insiders Place Their Bets

In related news, Director Pierre R. Breber bought 5,000 shares of the stock in a transaction on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the purchase, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. This trade represents a 38.46% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.63% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of research analyst reports. TD Cowen lifted their target price on Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $94.00 target price on shares of Clorox in a research report on Wednesday. Jefferies Financial Group dropped their price target on Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Zacks Research lowered Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. Finally, The Goldman Sachs Group reiterated a “sell” rating and issued a $83.00 price objective on shares of Clorox in a research note on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $102.80.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.